Vitamin D Deficiency-induced Hypertension Is Associated With Vascular Oxidative Stress and Altered Heart Gene Expression

Vitamin D deficiency (VDD) is associated with an increased cardiovascular risk. We investigated the effect of VDD on the cardiovascular system of growing male rats fed with a vitamin D-deficient diet. Using isolated rat aorta, we assessed both superoxide anion and endothelial-dependent relaxations. Microarray technology was used to identify changes induced by VDD in cardiac gene expression. Compared with control, VDD increased systolic blood pressure (P < 0.05) and superoxide anion production in the aortic wall (P < 0.05) and tended to increase serum levels of angiotensin II and atrial natriuretic peptide (P < 0.15). However, VDD slightly improved maximal relaxation to acetylcholine from 75 % ± 3% to 83% ± 2% (P < 0.05). Incubation of aortic rings either with nitro-l-arginine methyl ester (l-NAME) or catalase did not eliminate the enhancement of endothelial-mediated relaxation observed in vitamin D-deficient rats. Only incubation with indometacin or calcium-activated potassium channels blockers suppressed this difference. Compared with control, the expression of 51 genes showed different expression, including several genes involved in the regulation of oxidative stress and myocardial hypertrophy. In conclusion, VDD in early life increases arterial blood pressure, promotes vascular oxidative stress, and induces changes in cardiac gene expression. However, the endothelial-mediated regulation of vasomotor tone is maintained throughout the enhancement of an NO-independent compensatory pathway.

[1]  S. Ishiwata,et al.  Titin-based regulations of diastolic and systolic functions of mammalian cardiac muscle. , 2010, Journal of molecular and cellular cardiology.

[2]  P. Vanhoutte,et al.  The thromboxane/endoperoxide receptor (TP): the common villain. , 2010, Journal of cardiovascular pharmacology.

[3]  H. Shimokawa Hydrogen peroxide as an endothelium-derived hyperpolarizing factor , 2010, Pflügers Archiv - European Journal of Physiology.

[4]  J. Kroetsch,et al.  Nitric oxide and coronary vascular endothelium adaptations in hypertension , 2009, Vascular health and risk management.

[5]  T. Pieber,et al.  Vitamin D status and arterial hypertension: a systematic review , 2009, Nature Reviews Cardiology.

[6]  M. Yūksel,et al.  Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. , 2009, The Journal of clinical endocrinology and metabolism.

[7]  S. Hailpern,et al.  Prevalence and Associations of 25-Hydroxyvitamin D Deficiency in US Children: NHANES 2001–2004 , 2009, Pediatrics.

[8]  Lawrence J Appel,et al.  Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population , 2009, Pediatrics.

[9]  S. Goldman,et al.  Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults , 2009, European journal of nutrition.

[10]  M. Quon,et al.  Endothelial dysfunction in mice with streptozotocin-induced type 1 diabetes is opposed by compensatory overexpression of cyclooxygenase-2 in the vasculature. , 2009, Endocrinology.

[11]  J. O’Keefe,et al.  Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? , 2008, Journal of the American College of Cardiology.

[12]  W. März,et al.  Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. , 2008, The Journal of clinical endocrinology and metabolism.

[13]  S. Penckofer,et al.  The “Sunshine Deficit” and Cardiovascular Disease , 2008, Circulation.

[14]  M. Félétou,et al.  Aging and prostacyclin responses in aorta and platelets from WKY and SHR rats. , 2008, American journal of physiology. Heart and circulatory physiology.

[15]  P. Borne,et al.  Acute Effect of Sidestream Cigarette Smoke Extract on Vascular Endothelial Function , 2008, Journal of cardiovascular pharmacology.

[16]  P. Vanhoutte,et al.  Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. , 2008, American journal of physiology. Heart and circulatory physiology.

[17]  B. Boehm,et al.  Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. , 2008, Archives of internal medicine.

[18]  J. Sugden,et al.  Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[19]  Michael J. Pencina,et al.  Vitamin D Deficiency and Risk of Cardiovascular Disease , 2008, Circulation.

[20]  N. Chiamvimonvat,et al.  Ablation of sarcolipin enhances sarcoplasmic reticulum calcium transport and atrial contractility , 2007, Proceedings of the National Academy of Sciences.

[21]  G. London,et al.  Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. , 2007, Journal of the American Society of Nephrology : JASN.

[22]  M. Aldea,et al.  1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. , 2006, Kidney international.

[23]  G. Jagatheesan,et al.  Targeted Overexpression of Sarcolipin in the Mouse Heart Decreases Sarcoplasmic Reticulum Calcium Transport and Cardiac Contractility* , 2006, Journal of Biological Chemistry.

[24]  R. Koerfer,et al.  Putting cardiovascular disease and vitamin D insufficiency into perspective , 2005, British Journal of Nutrition.

[25]  Richard T. Lee,et al.  Hyperglycemia Promotes Oxidative Stress through Inhibition of Thioredoxin Function by Thioredoxin-interacting Protein* , 2004, Journal of Biological Chemistry.

[26]  Richard T. Lee,et al.  Thioredoxin-Interacting Protein Controls Cardiac Hypertrophy Through Regulation of Thioredoxin Activity , 2004, Circulation.

[27]  I. Fleming Cytochrome P450 epoxygenases as EDHF synthase(s). , 2004, Pharmacological research.

[28]  M. Holick,et al.  Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. , 2004, The American journal of clinical nutrition.

[29]  C. Dessy,et al.  Chronic Hydroxymethylglutaryl Coenzyme A Reductase Inhibition and Endothelial Function of the Normocholesterolemic Rat: Comparison With Angiotensin-Converting Enzyme Inhibition , 2002, Journal of cardiovascular pharmacology.

[30]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system , 2002 .

[31]  D. Wheeler,et al.  Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. , 2002, Journal of the American Society of Nephrology : JASN.

[32]  Patricia T W Cohen,et al.  Protein phosphatase 1--targeted in many directions. , 2002, Journal of cell science.

[33]  H. Minne,et al.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. , 2001, The Journal of clinical endocrinology and metabolism.

[34]  T. B. Paiva,et al.  Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. , 1999, Hypertension.

[35]  Arya M. Sharma,et al.  Ultraviolet B and blood pressure , 1998, The Lancet.

[36]  D. McMillan,et al.  Stress (heat shock) proteins: molecular chaperones in cardiovascular biology and disease. , 1998, Circulation research.

[37]  M. Haussler,et al.  Suppression of ANP gene transcription by liganded vitamin D receptor: involvement of specific receptor domains. , 1998, Hypertension.

[38]  A. Dobson,et al.  Seasons, temperature and coronary disease. , 1993, International journal of epidemiology.

[39]  R. Beaglehole,et al.  Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. , 1990, International journal of epidemiology.

[40]  R. Simpson,et al.  Vitamin D3 and cardiovascular function in rats. , 1987, The Journal of clinical investigation.

[41]  J. V. Levy Prostacyclin-induced contraction of isolated aortic strips from normal and spontaneously hypertensive rats (SHR). , 1980, Prostaglandins.

[42]  T. Oppé,et al.  Vitamin D deficiency. , 1979, British medical journal.

[43]  Guilin Qiao,et al.  Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. , 2005, American journal of physiology. Endocrinology and metabolism.

[44]  H. Granzier,et al.  The Giant Protein Titin A Major Player in Myocardial Mechanics , Signaling , and Disease , 2004 .

[45]  Shu Q. Liu,et al.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. , 2002, The Journal of clinical investigation.

[46]  G. Powis,et al.  Properties and biological activities of thioredoxins. , 2001, Annual review of biophysics and biomolecular structure.

[47]  J. Köhrle,et al.  Identification by differential display PCR of the selenoprotein thioredoxin reductase as a 1α,25(OH)_2‐vitamin D_3‐responsive gene in human osteoblasts — regulation by selenite , 1998, BioFactors.

[48]  J. Mironneau,et al.  Potassium channel activation in vascular smooth muscle. , 1992, Advances in experimental medicine and biology.